What is the appropriate prescribing dose of vitamin D (cholecalciferol)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Vitamin D Prescribing Dose Recommendations

For most adults requiring vitamin D supplementation, prescribe 800-2000 IU daily for maintenance, or use 50,000 IU weekly for 6-8 weeks to correct deficiency, followed by 800-2000 IU daily for maintenance. [@2,@3,1]

Maintenance Dosing (General Population)

Standard maintenance dose: 800-2000 IU daily [@2,@3,2]

  • For adults ≥65 years, dark-skinned individuals, veiled subjects with limited sun exposure, and institutionalized patients, 800 IU/day is the minimum recommended dose without baseline 25(OH)D measurement [@2,@3,1]
  • 2000 IU/day is increasingly recommended as a simple, effective dose that maintains 25(OH)D levels >50 nmol/L (20 ng/mL) in >99% of adults and >75 nmol/L (30 ng/mL) in >90% of adults [@13,@18@]
  • Intermittent equivalent: 100,000 IU every 3 months (approximately equal to 800 IU/day) [@2,@3,@5@]

Correction of Deficiency

For documented vitamin D deficiency (25(OH)D <30 ng/mL):

Loading Phase Options:

Option 1 (Most Common): 50,000 IU weekly for 6-8 weeks [@2,@3,@4,3]

  • This is the standard FDA-labeled dosing regimen 3
  • Effectively raises 25(OH)D levels in nearly all patients 4

Option 2 (Rapid Correction): 6000 IU daily for 4-12 weeks 2

  • Use when rapid correction is clinically indicated
  • Provides more consistent daily exposure 4

Option 3 (High-Risk Patients): 7000 IU daily or 30,000 IU twice weekly 5

  • Consider for obese patients, those with malabsorption syndromes, or liver disease 5
  • Can use 30,000 IU twice weekly for 6-8 weeks only 5

Maintenance After Correction:

800-2000 IU daily (or intermittent equivalent) [@2,@3,2]

Special Populations

Patients with Severe Deficiency (<10 ng/mL):

  • 300,000 IU single dose or 300,000 IU on two consecutive days (total 600,000 IU) can be used for rapid correction 6
  • Achieves levels >20 ng/mL in 98% of patients within one week 6
  • Follow with standard maintenance dosing

Patients with Malabsorption, Obesity, or Liver Disease:

  • Higher maintenance doses required: 7000 IU daily or 30,000 IU weekly 5
  • These patients may not respond adequately to standard 800-2000 IU daily dosing 5
  • Monitor 25(OH)D levels after 3 months to ensure adequacy [@4,@5@]

Patients with CKD (eGFR <30 mL/min):

  • May require biologically active vitamin D (calcitriol, paricalcitol, or doxercalciferol) rather than cholecalciferol [@1@]
  • Standard cholecalciferol can be used if eGFR ≥30 mL/min 1

Glucocorticoid-Induced Osteoporosis:

  • Vitamin D3 (cholecalciferol) or D2 (ergocalciferol) is recommended for patients with eGFR ≥30 mL/min without hyperparathyroidism 1
  • Combine with calcium supplementation to meet recommended daily allowances 1

Dosing Formulations and Schedules

Vitamin D3 (cholecalciferol) is preferred over D2 (ergocalciferol) for intermittent dosing regimens, as D3 maintains serum levels longer [@2,@3,@4@]

Intermittent Dosing Equivalents:

  • Daily 800 IU ≈ 100,000 IU every 3 months [@2,1]
  • Weekly or monthly schedules are acceptable alternatives to daily dosing [@2,@3@]
  • Avoid annual high-dose boluses (500,000 IU) as they may cause adverse outcomes [@2,@3,@5@]

Monitoring

Check 25(OH)D levels after at least 3 months of supplementation [@4,1]

  • Target range: 30-50 ng/mL (75-125 nmol/L) 2
  • For intermittent dosing, measure just before the next dose 1
  • Routine monitoring not needed for low-risk patients on standard maintenance doses [@2,1]

Monitor in high-risk groups:

  • Patients with malabsorption syndromes [@2,@3,@13@]
  • Obese patients [@11@]
  • Those on medications affecting vitamin D metabolism 5

Safety Considerations

Upper safety limit: 25(OH)D level of 100 ng/mL [@2,@3,@5@]

  • Toxicity rarely occurs with daily doses <10,000 IU [@2,@5,@9@]
  • Hypercalcemia typically only occurs with daily intake >100,000 IU or 25(OH)D >100 ng/mL [@2,@3,1]
  • Optimal target range is 30-50 ng/mL; levels >50 ng/mL provide no additional benefit [@2,1]
  • Reduce supplementation if levels reach 70-80 ng/mL, though this range is safe [@2,1]

Practical Dosing Algorithm

Rule of thumb: 1000 IU daily increases 25(OH)D by approximately 10 ng/mL [@2,@3,@4@]

For calculated loading doses:

  • Dose (IU) = 40 × (75 - current 25(OH)D level) × body weight (kg) [@15

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.